Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 07:00PM GMT
Release Date Price: $4.28 (-4.68%)
Gil Blum
Needham & Company - Analyst

Good afternoon, everyone, and thank you for joining us at the second day of the Needham and Company Healthcare Conference. My name is Gil Blum, and I am a senior biotech analyst here at Needham & Co., and I cover both the gene therapy and immuno-oncology subsectors. It is my pleasure to have with me today, Geoff McDonough, the CEO of Generation Bio. (Conference Instructions)

Questions & Answers

Gil Blum
Needham & Company - Analyst

Without further ado, we can get started. Some people don't know the Generation Bio story too well. Maybe as an introduction, just talk a little bit about the technology. And what is the problem that you're really trying to solve?

Geoff McDonough
Generation Bio Co. - President & Chief Executive Officer

Thanks, Gil, and thanks for the invitation to be here. It's always fun to chat and [it'd] be a great half an hour together.

Generation Bio is about redosable DNA therapeutics at scale and let's just parse what that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot